Atlas Trials

Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites

Clinical trial NCT05745233 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT05745233
Sponsor
China Medical University Hospital
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Malignant Ascites
Start date
2021-01-01
Primary completion
2026-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.